Clinical Trial Update: Riluzole to Treat Major Depression [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating riluzole for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Depression | Phase 2 | Status: COMPLETED